Abstract: A solenoid valve (10) comprises a coil core (15), a yoke (16), a valve chamber (13), an inlet armature (11) upstream of an inlet (17) of the valve chamber (13), an outlet armature (12) upstream of a first outlet (18) of the valve chamber (13), and a second outlet (19) at the valve chamber (13), wherein the inlet armature (11) and outlet armature (12) can move and the inlet (17) and first outlet (18) lie opposite one another. In the solenoid valve (10), the inlet (17) and the second outlet (19) are connected to one another by way of an equalizing system having a non-return valve (25), wherein the non-return valve (25) is open towards the inlet (17).

Abstract: A solenoid valve (10) comprises a coil core (15), a yoke (16), a valve chamber (13), an inlet armature (11) upstream of an inlet (17) of the valve chamber (13), an outlet armature (12) upstream of a first outlet (18) of the valve chamber (13), and second outlet (19) at the valve chamber (13), wherein the inlet armature (11) and outlet armature (12) can move and the inlet (17) and first outlet (18) lie opposite one another. In the solenoid valve (10), the inlet (17) and the second outlet (19) are connected to one another by way of an equalizing system having a non-return valve (25), wherein the non-return valve (25) is open towards the inlet (17).

Abstract: Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseasesPropane derivatives of the formula I ##STR1## in which the radicals have the meanings stated in the description, a process for the preparation of these compounds, their use as pharmaceuticals, and pharmaceutical products are described. Also described are novel intermediates for preparing the compounds of the formula I.

Abstract: Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseasesCyclohexane derivatives of the formula I ##STR1## wherein R.sup.2, R.sup.4 and R.sup.5 have the given meanings and a process for their preparation are described. The compounds have useful pharmacological properties and can therefore be used as pharmaceuticals.

Abstract: Cyclohexanol esters of the formula I ##STR1## are described in which the radicals have the given meaning. The compounds are pharmacologically active and may therefore be used as pharmaceuticals, in particular for treating diabetes and other diseases which are characterized by an elevated secretion of glucose from the liver or by an elevated activity of the glucose-6-phosphatase system.